Vijaya Diagnostic Centre Limited share price

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, and molecular diagnostics; radiology services, such as CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, and gastroenterology; and advance radiology service comprising nuclear medicine, positron emission tomography CT, and MRI-3T services. It also provides health checkups and home sample collection services, as well as test services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.Read more

Website NSE BSE

HealthcareDiagnostics & ResearchNifty 500 Nifty Smallcap 250NSE: VIJAYAISIN INE043W01024

16 Oct 2026, 3:29 PM IST₹1,381.70▼ 5.70 (0.41%)

Market Cap₹ 14,231 Cr.
Current Price₹ 1,381.70
High / Low₹ 1,594 / 848
Stock P/E76.0
Book Value₹ 93
Dividend Yield0.14 %
ROCE19.1 %
ROE19.70 %
Face Value₹ 1.0

More figures (10)

EPS (TTM)₹ 18.19
Price / Book14.85
OPM30.1 %
Debt / Equity0.44
Sales growth (3Y)21.0 %
Profit growth (3Y)26.6 %
Promoter holding53.5 %
EV / EBITDA38.7
Beta0.36
All-time high₹ 1,594

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
VIJAYA	-3.94%	-2.18%	+35.57%	+30.23%	+37.87%	+35.61%	+19.19%
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

Vijaya Diagnostic Centre Limited is in the Diagnostics & Research industry (Healthcare), with a market value of ₹14,231 crore.
It trades at 76.0 times its last 12 months' earnings and 14.8 times book value.
Revenue grew 21.0% a year over the last 3 years, profit 26.6% a year.
Return on equity was 19.7% and return on capital employed 19.1% in the latest year.
Debt was 0.44 times shareholders' equity.
The share price is 13.3% below its 52-week high and up 37.9% over one year.
Promoters and insiders hold about 53.5%; institutions about 39.4%.

Pros

Strong return on equity: 19.7% on average over the last 3 years.
Sales have grown 21.0% a year over the last 3 years.
Profit has grown 26.6% a year over the last 3 years.
Latest quarter (Jun 2026): sales up 23% and profit up 38% from a year ago.
Institutional (FII + DII) holding has risen by 3.4 points over 3 years.

Cons

Promoter holding has fallen by 2.41 points over 3 years, to 52.46%.
Trades at 14.8 times its book value.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About Vijaya Diagnostic Centre Limited

Employees: 2,507
Head office: Hyderabad
NSE industry: Healthcare

Peer comparison

Company	Market cap (₹ Cr)	P/E	P/B	ROE	OPM	Sales CAGR	Div. yield
Vijaya Diagnostic Centre LimitedVIJAYA	14,231	76.0	14.85	19.7%	30.1%	+21.0%	0.14%
Sun Pharmaceutical Industries LimitedSUNPHARMA	4,21,995	34.9	5.05	14.7%	23.4%	+10.4%	0.91%
Divi's Laboratories LimitedDIVISLAB	2,42,758	83.0	14.48	16.2%	28.4%	+11.0%	0.33%
Torrent Pharmaceuticals LimitedTORNTPHARM	1,73,406	72.8	18.39	27.1%	25.0%	+13.3%	0.83%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP	1,13,446	54.3	11.97	21.9%	11.7%	+14.8%	0.25%
Zydus Lifesciences LimitedZYDUSLIFE	1,12,020	25.0	4.17	19.7%	21.7%	+16.5%	0.09%
Cipla LimitedCIPLA	1,07,051	31.8	3.11	11.8%	17.5%	+7.2%	0.98%
Dr. Reddy's Laboratories LimitedDRREDDY	1,02,707	31.0	2.68	12.1%	14.9%	+11.0%	0.66%
Max Healthcare Institute LimitedMAXHEALTH	82,342	56.7	7.66	14.3%	22.8%	+22.4%	0.23%
Abbott India LimitedABBOTINDIA	55,609	34.4	11.65	34.5%	26.3%	+9.0%	2.01%

Companies in the same industry (Diagnostics & Research). Tap a heading to sort. Sorting is a way to explore data, not a recommendation.

Quarterly Results

Consolidated figures in ₹ crore /

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	121	139	133	155	156	183	169	173	188	202	205	219	231
YOY Sales Growth %				28.28%	29.05%	31.75%	27.35%	11.62%	20.38%	10.17%	21.44%	26.63%	22.83%
	73	81	80	92	95	107	102	104	115	120	119	124	132
Material Cost %	12%	12%	12%	12%	12%	13%	12%	13%	11%	12%	12%	11%	11%
Employee Cost %	17%	16%	17%	16%	18%	15%	17%	16%	17%	16%	16%	15%	16%
Other Expenses %	31%	31%	31%	31%	31%	31%	31%	31%	33%	31%	30%	30%	30%
Operating Profit	48	57	52	63	61	76	67	69	74	82	86	96	99
OPM %	40%	41%	39%	41%	39%	42%	40%	40%	39%	41%	42%	44%	43%
	6	7	5	3	4	5	5	6	7	6	5	2	9
Exceptional items			-2					-1
Interest	6	6	6	6	6	6	7	7	7	8	9	9	11
Depreciation	12	14	15	16	17	17	18	19	21	22	24	24	25
Profit before tax	35	45	35	44	42	57	47	47	52	58	58	64	71
	26%	25%	25%	23%	25%	26%	24%	26%	26%	25%	26%	25%	25%
Current tax	7	9	9	8	10	13	9	9	12	13	12	15	17
Deferred tax	2	2	-0	2	1	2	2	3	2	2	3	2	1
	26	34	26	34	32	42	35	35	39	43	43	48	53
Minority share	0	0	0	0	0	0	0	0	0
Profit to shareholders	26	33	26	33	31	42	35	35	38	43	43	48	53
YOY Profit Growth %				21.46%	19.41%	25.47%	35.76%	3.52%	22.48%	2.75%	22.31%	37.47%	37.61%
EPS in Rs	2.57	3.26	2.53	3.27	3.06	4.09	3.42	3.38	3.76	4.21	4.20	4.66	5.16
Raw filing

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	119	136	129	141	142	169	156	160	175	189	193	206	219
YOY Sales Growth %				19.20%	19.96%	23.86%	21.02%	13.33%	22.76%	12.30%	23.57%	29.04%	24.99%
	71	80	78	84	87	98	94	96	105	111	110	115	124
Material Cost %	12%	12%	12%	12%	12%	13%	13%	13%	11%	12%	12%	11%	11%
Employee Cost %	17%	16%	17%	16%	17%	15%	17%	16%	17%	16%	16%	15%	16%
Other Expenses %	31%	31%	31%	31%	31%	31%	31%	31%	32%	31%	29%	29%	30%
Operating Profit	47	56	51	57	56	70	62	64	69	79	83	91	95
OPM %	40%	41%	40%	41%	39%	42%	40%	40%	40%	41%	43%	44%	43%
	6	7	5	3	4	5	5	6	7	5	6	7	9
Exceptional items			-2					-1
Interest	6	6	6	6	6	6	6	7	7	7	8	9	10
Depreciation	12	14	14	15	15	15	17	17	18	19	21	21	22
Profit before tax	35	44	34	40	38	54	44	45	52	57	59	68	71
	26%	25%	25%	23%	25%	26%	24%	27%	26%	25%	25%	23%	25%
Current tax	7	9	9	7	9	12	9	9	11	12	12	15	17
Deferred tax	2	2	-0	2	1	2	2	3	2	2	3	1	1
	26	33	25	31	29	39	34	33	38	43	44	53	53
YOY Profit Growth %				13.32%	11.02%	20.24%	32.82%	8.55%	33.01%	8.11%	31.85%	58.98%	38.44%
EPS in Rs	2.55	3.21	2.47	2.98	2.82	3.85	3.26	3.23	3.74	4.15	4.30	5.12	5.17
Raw filing

Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Consolidated figures in ₹ crore /

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	462	459	548	681	814	857
YOY Sales Growth %		-0.68%	19.29%	24.39%	19.49%
	259	277	327	408	477	495
Material Cost %	15%	13%	12%	12%	12%	12%
Employee Cost %	15%	17%	16%	16%	16%	16%
Other Expenses %	25%	30%	31%	31%	31%	30%
Operating Profit	204	182	221	273	337	362
OPM %	44%	40%	40%	40%	41%	42%
	13	14	21	18	21	22
Exceptional items			-2	-1
Interest	16	21	24	27	33	37
Depreciation	53	62	57	71	92	96
Profit before tax	147	114	159	193	233	251
	25%	25%	25%	26%	26%	25%
Current tax	40	28	33	41	51
Deferred tax	-3	1	6	8	9
	111	85	120	144	173	187
Minority share	1	1	1	1
Profit to shareholders	110	85	119	143	173	187
YOY Profit Growth %		-23.01%	40.41%	20.19%	20.30%
EPS in Rs	10.76	8.29	11.62	13.95	16.81	18.23
Dividend Payout %		12%	9%	7%	12%

Compounded Sales Growth

3 Years:: 21%
TTM:: 20%

Compounded Profit Growth

3 Years:: 27%
TTM:: 24%

Stock Price CAGR

5 Years:: 19%
3 Years:: 36%
1 Year:: 38%

Return on Equity

4 Years:: 19%
Last Year:: 20%

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	451	450	525	627	765	807
YOY Sales Growth %		-0.29%	16.78%	19.45%	22.05%
	251	271	313	375	443	460
Material Cost %	15%	13%	12%	13%	12%	12%
Employee Cost %	15%	17%	16%	16%	16%	16%
Other Expenses %	25%	30%	31%	31%	30%	30%
Operating Profit	200	179	212	253	322	347
OPM %	44%	40%	40%	40%	42%	43%
	13	15	21	19	25	27
Exceptional items			-2	-1
Interest	16	21	24	25	31	34
Depreciation	52	61	55	65	80	84
Profit before tax	144	111	152	181	236	255
	25%	25%	25%	26%	25%	25%
Current tax	39	28	32	39	50
Deferred tax	-3	1	6	8	8
	108	83	115	135	178	193
YOY Profit Growth %		-23.01%	37.69%	17.81%	32.07%
EPS in Rs	10.60	8.16	11.21	13.16	17.33	18.74
Dividend Payout %		12%	9%	8%	12%

Compounded Sales Growth

3 Years:: 19%
TTM:: 22%

Compounded Profit Growth

3 Years:: 29%
TTM:: 33%

Stock Price CAGR

5 Years:: 19%
3 Years:: 36%
1 Year:: 38%

Return on Equity

4 Years:: 19%
Last Year:: 20%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10	10	10	10
Reserves	535	647	789	947
Borrowings	248	259	320	423
	61	66	155	127
Trade payables	28	33	33	38
Minority interest	2	3	3
Current liabilities	66	73	163	124
Total Liabilities	853	983	1,274	1,507
	550	615	802	977
Gross block	822	935	1,190	1,444
Accumulated depreciation	272	321	388	467
Goodwill & intangibles	8	140	141	140
CWIP	34	13	79	48
	270	356	393	482
Inventories	2	5	5	5
Trade receivables	9	16	15	21
Cash & equivalents	24	22	13	40
Current assets	276	211	307	322
Total Assets	853	983	1,274	1,507

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	165	183	224	271
Profit for the year	85	119	144	173
Working capital changes	9	-1	-7	-17
Direct taxes paid	-26	-34	-40	-52
	-110	-142	-182	-174
Fixed assets purchased	-125	-88	-96	-183
Fixed assets sold	0	3	3	3
Investments purchased	-80	-209	-151	-82
Investments sold	89	291	59	81
	-42	-45	-52	-69
Repayment of borrowings	-1
Interest paid	-0	-21	-24	-31
Dividends paid	-10	-10	-10	-21
Net Cash Flow	13	-4	-9	27
Free Cash Flow	40	95	129	88

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	—	15.5%	19.8%	19.7%	19.7%
ROCE	—	16.9%	19.9%	19.6%	19.1%
Operating margin	—	26.2%	29.9%	29.8%	30.1%
Net margin	—	18.4%	21.7%	21.1%	21.3%
Debt / equity	—	0.45	0.39	0.40	0.44
Current ratio	—	4.17	2.90	1.89	2.60

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities).

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

Promoters 52.46%
FIIs 10.66%
DIIs 32.50%
Public 4.38%

%	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	54.87%	54.06%	53.93%	53.91%	53.91%	53.05%	52.63%	52.60%	52.60%	52.51%	52.51%	52.46%
	19.95%	20.09%	20.08%	18.14%	17.54%	19.36%	19.56%	18.27%	15.10%	13.38%	11.66%	10.66%
Foreign portfolio investors (Cat. I)	19.74%	19.87%	19.84%	17.71%	16.95%	16.03%	16.40%	14.97%	12.54%	11.13%	9.77%	9.13%
Foreign portfolio investors (Cat. II)	0.21%	0.22%	0.24%	0.43%	0.59%	3.33%	3.16%	3.30%	2.56%	2.25%	1.88%	1.54%
	19.83%	20.80%	21.49%	23.46%	24.63%	23.72%	24.07%	25.34%	28.59%	29.93%	31.61%	32.50%
Mutual funds	19.41%	20.37%	20.90%	22.87%	23.97%	23.67%	23.55%	24.80%	27.98%	29.06%	30.66%	31.44%
Insurance companies	0.14%	0.21%	0.44%	0.50%	0.55%	0.01%	0.48%	0.51%	0.51%	0.51%	0.57%	0.53%
Alternative investment funds	0.27%	0.22%	0.15%	0.08%	0.10%	0.04%	0.04%	0.03%	0.11%	0.36%	0.38%	0.52%
	5.35%	5.05%	4.50%	4.49%	3.92%	3.87%	3.74%	3.79%	3.71%	4.18%	4.23%	4.38%
Retail (up to ₹2 lakh)	4.63%	4.38%	3.98%	3.94%	3.43%	3.42%	3.24%	3.20%	3.14%	3.47%	3.49%	3.55%
NRIs	0.25%	0.23%	0.17%	0.17%	0.16%	0.17%	0.13%	0.22%	0.23%	0.23%	0.24%	0.26%
Bodies corporate	0.37%	0.32%	0.26%	0.29%	0.25%	0.20%	0.14%	0.14%	0.13%	0.17%	0.30%	0.32%
No. of Shareholders	66,204	66,724	62,415	62,258	60,952	66,891	62,115	58,994	57,784	62,946	67,251	70,966

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

None filed recently.

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Ex-dividend date: 16 Sep 2026
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Questions about Vijaya Diagnostic Centre Limited

What is the share price of Vijaya Diagnostic Centre Limited today?

Vijaya Diagnostic Centre Limited (VIJAYA) last traded at ₹1,381.70 on NSE (16 Oct 2026, 3:29 PM IST). Prices may be delayed.

What is the market cap of Vijaya Diagnostic Centre Limited?

About ₹14,231 crore at the latest price.

What is the P/E ratio of Vijaya Diagnostic Centre Limited?

About 76.0 times its earnings over the last 12 months.

Is Vijaya Diagnostic Centre Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy Vijaya Diagnostic Centre Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.

Vijaya Diagnostic Centre Limited share price

Price chart

Quick take

Pros

Cons

AI analysis

About Vijaya Diagnostic Centre Limited

Peer comparison

Quarterly Results

Profit & Loss

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings

Concalls & investor meets

Key dates

Trade with our broking desk

Questions about Vijaya Diagnostic Centre Limited

Have a question about this topic?

Book your free wealth consultation

Request received!

What happens next